Showing results (241-250 of 269) with videos related to
Sort By:
Pageof 27
Bioorganic & Medicinal Chemistry Letters|May 6, 2023
Synthesis of 6-alkoxy and 6-hydroxy-alkyl amine derivatives of braylin as vasorelaxing agentsKripa Shankar Nainawat, Sarita Singh, Karishma Agarwal, et al.European Journal of Immunology|August 21, 2012
The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cellsZoë Urry, Emma S Chambers, Emmanuel Xystrakis, et al.Bioorganic Chemistry|February 2, 2023
Synthesis of amide derivatives of 3-aryl-3H-benzopyrans as osteogenic agent concomitant with anticancer activitySarita Singh, Surendra Chandra Verma, Vinay Kumar, et al.Thorax|October 19, 2019
Differences in lung function between children with sickle cell anaemia from West Africa and EuropeMichele Arigliani, Luigi Castriotta, Ramatu Zubair, et al.British Journal of Clinical Pharmacology|July 6, 2026
Pharmacokinetics and safety of tezepelumab in children with mild, moderate or severe asthma and adolescents with mild-to-moderate asthmaAnna Lundahl, Jonathan Grigg, Lubna Abuqayyas, et al.Plos One|December 19, 2025
Protocol for an open labelled observational study in children & adolescents with severe asthma with an eosinophilic phenotype treated with mepolizumab (CASAM)Atul Gupta, Ines de Mir Messa, Jose Valverde-Molina, et al.Journal of Asthma and Allergy|February 13, 2024
Impact of Lung Function on Asthma Exacerbation Rates in Children Treated with Dupilumab: The VOYAGE StudyTheresa W Guilbert, Kevin R Murphy, Eckard Hamelmann, et al.European Journal of Pediatrics|September 13, 2025
Dynamics of RSV hospitalization rates in ≤ 2-year-old children between 2020-2023 in EuropeJoanne G Wildenbeest, Louis Bont, Daniela Cianci, et al.ERJ Open Research|October 8, 2024
High-flow humidified oxygen as an early intervention in children with acute severe asthma: a feasibility randomised controlled trialAkshat Kapur, Héctor Rojas-Anaya, Graham Roberts, et al.BMJ Open|August 22, 2024
Treating severe paediatric asthma with mepolizumab or omalizumab: a protocol for the TREAT randomised non-inferiority trialVictoria Cornelius, Daphne Babalis, William D Carroll, et al.Pageof 27